Bristol-Myers Squibb Co (NYSE:BMY)

50.53
Data as of Oct 01
 -0.65 / -1.27%
Today’s Change
46.14
Today|||52-Week Range
57.49
-4.93%
Year-to-Date
Bristol-Myers' Opdivo under Review in EU for Lung Cancer - Analyst Blog
Oct 01 / Zacks.com
Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog
Sep 26 / Zacks.com
AbbVie Announces Positive Results on Oncology Candidate - Analyst Blog
Oct 01 / Zacks.com
Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance - Analyst Blog
Sep 26 / Zacks.com
Abbott Labs Completes CFR Pharmaceuticals Acquisition - Analyst Blog
Oct 01 / Zacks.com
Pfizer Acquires InnoPharma, Injectables Business to Benefit - Analyst Blog
Sep 26 / Zacks.com
Valeant's Bausch + Lomb Announces Results on Lotemax - Analyst Blog
Sep 30 / Zacks.com
Roche Announces Positive Results from Studies on Avastin - Analyst Blog
Sep 26 / Zacks.com
Big News for These 5 Stocks From ESMO
Sep 30 / MotleyFool.com
BMY, MRK And PFE, 3 Drugs Stocks Pushing The Industry Lower
Sep 26 / TheStreet.com
Bristol-Myers' Opdivo Under Review in US, EU for Cancer Treatment - Analyst Blog
Sep 29 / Zacks.com
Finding a Place to Hide
Sep 26 / TheStreet.com
Roche Releases Data from CLEOPATRA Study on Perjeta - Analyst Blog
Sep 29 / Zacks.com
Jim Cramer's 'Mad Money' Recap: Here's Why Timing is Everything
Sep 25 / TheStreet.com
Novartis Gives Updates on Signifor LAR and Secukinumab - Analyst Blog
Sep 29 / Zacks.com
Valeant (VRX) Sends Letter to Allergan, Provides Q3 Update - Analyst Blog
Sep 25 / Zacks.com
3 Stocks Reiterated As A Buy: BMY, CAT, AXP
Sep 29 / TheStreet.com
Bristol-Myers Squibb Company (BMY): New Analyst Report from Zacks Equity Research - Z...
Sep 23 / Zacks.com
Gilead Sciences, Inc., Merck & Co., Inc., Bristol-Myers Squibb Co: Getting A Boost Fr...
Sep 29 / Investing Channel
Surprising Silver Lining for Gilead Sciences, inc. Stock
Sep 22 / MotleyFool.com
Bristol-Myers Squibb Company (BMY) Showing Unusual Social Activity Today
Sep 29 / TheStreet.com
Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog
Sep 19 / Zacks.com
Fast Money Picks For September 29 - Yahoo! Inc., Exxon Mobil Corporation And More
Sep 29 / Benzinga
Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog
Sep 18 / Zacks.com
Gilead Sciences, Inc. Takes Aim at Bristol-Myers Squibb
Sep 29 / MotleyFool.com
Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
Sep 18 / MotleyFool.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.